Alabama’s Stop-Sale System Achieves Significant Results In Battle Against Meth
LUTHERVILLE, Md., July 9, 2012 /PRNewswire/ — The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest results achieved by the real-time, stop-sale system in Alabama. The National Precursor Log Exchange (NPLEx) released data for 2012 which shows that so far this year, electronic technology in the Yellowhammer State blocked the sale of more than 45,000 boxes of medicine containing pseudoephedrine (PSE) preventing more than 112,000 grams from potentially being diverted by meth criminals. NPLEx was fully implemented in Alabama in January 2011.
“In the year and a half since Alabama launched its real-time blocking system, NPLEx has blocked thousands of attempted pseudoephedrine purchases and kept hundreds of thousands of grams out of the hands of criminals,” said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). “Alabama police officers use NPLEx data to build stronger cases and make arrests. By targeting criminals, this proven system protects responsible consumers’ access to popular and reliable medicines containing pseudoephedrine. Earlier this year, Alabama lawmakers passed legislation that will make NPLEx even stronger, so that more criminals seeking to misuse reliable and popular medicines end up behind bars.”
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators